Sex disparities in liver transplantation for hepatocellular carcinoma: long-term outcomes and recurrence predictors.
1/5 보강
[BACKGROUND] With a 2- to 3-fold higher incidence in men, hepatocellular carcinoma (HCC) is the leading indication for liver transplantation (LT).
APA
El-Domiaty N, Coilly A, et al. (2025). Sex disparities in liver transplantation for hepatocellular carcinoma: long-term outcomes and recurrence predictors.. Translational gastroenterology and hepatology, 10, 69. https://doi.org/10.21037/tgh-25-4
MLA
El-Domiaty N, et al.. "Sex disparities in liver transplantation for hepatocellular carcinoma: long-term outcomes and recurrence predictors.." Translational gastroenterology and hepatology, vol. 10, 2025, pp. 69.
PMID
41216273 ↗
Abstract 한글 요약
[BACKGROUND] With a 2- to 3-fold higher incidence in men, hepatocellular carcinoma (HCC) is the leading indication for liver transplantation (LT). Despite this sex disparity in HCC incidence, the influence of recipient sex on long-term LT outcomes, including HCC recurrence, is not well established. This study investigates the impact of recipient sex on the long-term outcomes following LT for HCC.
[METHODS] All consecutive patients undergoing LT for HCC between 2005 and 2018 were retrospectively analyzed. Data regarding patient demographics, tumor characteristics, and post-transplant outcomes were collected, and recipients were stratified by sex. Kaplan-Meier analysis was used to assess overall and recurrence-free survival (RFS). Multivariable Cox regression models were then used to determine independent predictors of HCC recurrence within each sex group.
[RESULTS] Of the 384 adult recipients (mean age was 58.7±8.4 years and mean follow-up of 86.5±51.5 months), 17.2% of patients were female. The main etiology of cirrhosis in the female and male groups was alcohol-related (19.7%, 36.5%), HCV (40.9%, 24.5%) and metabolic dysfunction-associated steatohepatitis (MASH) (10.6%, 12.3%). The Model for End-Stage Liver Disease (MELD) and Child-Pugh scores were similar in both groups. 87.9% and 76.4% of the patients were within the Milan criteria and 95.5% and 91.5% of the patients had an alpha-fetoprotein (AFP) score ≤2 at the time of LT, respectively. The 1-, 3-, 5-, 10- and 15-year survival rates were similar in the male and female groups (91.5%, 81.5%, 72.4%, 57.7% and 44.9% . 89.4%, 80.1%, 72.0%, 50.0% and 29.6%, P=0.43). Microvascular invasion was seen in 30.3% and 36.3% of the patients, respectively, P=0.36). Recurrence rates were comparable in female and male groups (19.7% . 20.1%, respectively, P=0.94). The 10-year RFS rate was 50.6% in the female group and 54.9% in the male group (P=0.61).
[CONCLUSIONS] Recipient sex does not impact long-term survival or HCC recurrence after LT. However, sex-specific predictors of HCC recurrence were identified: AFP score >2 and prior hepatectomy in females, and these plus diabetes mellitus and older age in males. Furthermore, female recipients presented with a significantly lower incidence of alcohol-associated cirrhosis as the underlying cause of HCC.
[METHODS] All consecutive patients undergoing LT for HCC between 2005 and 2018 were retrospectively analyzed. Data regarding patient demographics, tumor characteristics, and post-transplant outcomes were collected, and recipients were stratified by sex. Kaplan-Meier analysis was used to assess overall and recurrence-free survival (RFS). Multivariable Cox regression models were then used to determine independent predictors of HCC recurrence within each sex group.
[RESULTS] Of the 384 adult recipients (mean age was 58.7±8.4 years and mean follow-up of 86.5±51.5 months), 17.2% of patients were female. The main etiology of cirrhosis in the female and male groups was alcohol-related (19.7%, 36.5%), HCV (40.9%, 24.5%) and metabolic dysfunction-associated steatohepatitis (MASH) (10.6%, 12.3%). The Model for End-Stage Liver Disease (MELD) and Child-Pugh scores were similar in both groups. 87.9% and 76.4% of the patients were within the Milan criteria and 95.5% and 91.5% of the patients had an alpha-fetoprotein (AFP) score ≤2 at the time of LT, respectively. The 1-, 3-, 5-, 10- and 15-year survival rates were similar in the male and female groups (91.5%, 81.5%, 72.4%, 57.7% and 44.9% . 89.4%, 80.1%, 72.0%, 50.0% and 29.6%, P=0.43). Microvascular invasion was seen in 30.3% and 36.3% of the patients, respectively, P=0.36). Recurrence rates were comparable in female and male groups (19.7% . 20.1%, respectively, P=0.94). The 10-year RFS rate was 50.6% in the female group and 54.9% in the male group (P=0.61).
[CONCLUSIONS] Recipient sex does not impact long-term survival or HCC recurrence after LT. However, sex-specific predictors of HCC recurrence were identified: AFP score >2 and prior hepatectomy in females, and these plus diabetes mellitus and older age in males. Furthermore, female recipients presented with a significantly lower incidence of alcohol-associated cirrhosis as the underlying cause of HCC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Associations Between Sex, Disease Features and Outcome in Patients With Acute Myeloid Leukemia: A Sex-Stratified Analysis of the GIMEMA AML1310 Trial.
- Sexual function in chronic illness and cancer perspectives of the patient, partner, and healthcare provider; innovations; and updates: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).
- Intra-procedural Cone-Beam Computed Tomography for Ultrasound-Guided Microwave Ablation of Hepatocellular Carcinoma: An Initial Experience.
- BRCA1 and BRCA2 pathogenic variants increase the risk of four less common cancer types.
- Matrix Metalloproteinases in Hepatocellular Carcinoma: Mechanistic Roles and Emerging Inhibitory Strategies for Therapeutic Intervention.
- Patient-Clinician Sex and Race and/or Ethnicity Concordance and Adherence to Preventive Services Guidelines: MEPS 2018-2020.